Table 1.
Baseline characteristics of patients with COVID-19
| LPV/r group (n = 22) | Combination group (n = 19) | P-value | |
|---|---|---|---|
| Age, year (mean ± SD) | 62.0 ± 9.4 | 56.2 ± 9.7 | 0.058 |
| Male, n (%) | 8 (36) | 10 (53) | 0.295 |
| Days from symptom onset to hospital admission (mean ± SD) | 11 ± 6.8 | 12 ± 7.3 | 0.214 |
| Coexisting medical conditions, n (%) | |||
| Hypertension | 5 (22.7) | 4 (21.1) | 1.000 |
| Diabetes | 5 (22.7) | 6 (31.6) | 0.524 |
| Hepatitis | 1 (4.5) | 0 (0) | 1.000 |
| Malignancy | 1 (4.5) | 2 (10.5) | 0.895 |
| Symptoms, n (%) | |||
| Cough | 13 (59) | 10 (52.6) | 0.678 |
| Shortness of breath | 6 (27.3) | 4 (21.1) | 0.922 |
| Pharyngalgia | 2 (9) | 4 (21.1) | 0.524 |
| Arthralgia/myalgia | 7 (31.8) | 4 (21.1) | 0.438 |
| Chest pain | 4 (18.2) | 2 (10.5) | 0.804 |
| Fatigue | 7 (31.8) | 9 (47.4) | 0.309 |